Cord blood stem cells aim to repair hearts after attack
NCT ID NCT07134712
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new treatment called MiSaver, made from umbilical cord blood cells, for people who recently had a heart attack. The goal is to see if it safely helps the heart pump better and reduces future heart problems. About 102 participants will either receive the cell treatment or standard care, and their heart function will be tracked for a year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chung Shan Medical University Hospital Daqing Branch
Taichung, Taiwan
-
Flinders Medical Centre
Bedford Park, South Australia, 5042, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
-
Mackay Memorial Hospital Hsinchu Branch
Hsinchu, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could aging clues in the blood predict heart attack recovery?
- Blood filter may tame deadly inflammation after heart attack
- New PET scan may predict heart failure risk after heart attack
- Massive study tracks cost and use of heart attack meds in US and germany
- AI breakthrough could spot hidden heart attacks in patients with tricky ECG patterns
- Heart attack patients get a closer look: MRI study aims to sharpen prognosis